Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma. Neppelenbroek SIM, Geurts YM, Aleman BMP, Lugtenburg PJ, et al. J Clin Oncol 2024 Feb 15:JCO2301386. doi: 10.1200/JCO.23.01386.

Read + Share

Amedeo Smart

Independent Medical Education

Neppelenbroek SIM, Geurts YM, Aleman BMP, Lugtenburg PJ, et al. Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma. J Clin Oncol 2024 Feb 15:JCO2301386. doi: 10.1200/JCO.23.01386.
PMID: 38359378